课题基金 / 基金详情

项目摘要

项目成果

Jason Matthew Elinoff的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Part 1 of this study has been completed. Over the past year, we have continued to develop the necessary technical skills in rodent cardiac catheterization and cardiac magnetic resonance imaging. We have implemented cardiac resonance imaging as part of the protocol instead of echocardiography in order to improve both the resolution and precision of our assessments of right ventricular function. Part 2 of the study, determining the effects of spironolactone versus eplerenone, began in May 2017 and we have completed the first set of experiments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Phase 1 Clinical Trial of ABI-009, an mTOR Inhibitor, for Patients with Severe Pulmonary Arterial Hypertension (PAH)
  • 批准号:
    10683664
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Jason Matthew Elinoff
  • 依托单位:
A Phase 1 Clinical Trial of ABI-009, an mTOR Inhibitor, for Patients with Severe Pulmonary Arterial Hypertension (PAH)
  • 批准号:
    10262632
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Jason Matthew Elinoff
  • 依托单位:
The Effects of Spironolactone on Inflammation in a Rodent Model of Pulmonary Arterial Hypertension
  • 批准号:
    10683663
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Jason Matthew Elinoff
  • 依托单位:
The Effects of Spironolactone on Inflammation in a Rodent Model of Pulmonary Arterial Hypertension
  • 批准号:
    10262630
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Jason Matthew Elinoff
  • 依托单位:
海外基金